152 related articles for article (PubMed ID: 2995494)
1. Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding.
Ramstedt U; Ng J; Wigzell H; Serhan CN; Samuelsson B
J Immunol; 1985 Nov; 135(5):3434-8. PubMed ID: 2995494
[TBL] [Abstract][Full Text] [Related]
2. Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: studies on stereospecificity of inhibition and mode of action.
Ramstedt U; Serhan CN; Nicolaou KC; Webber SE; Wigzell H; Samuelsson B
J Immunol; 1987 Jan; 138(1):266-70. PubMed ID: 3782800
[TBL] [Abstract][Full Text] [Related]
3. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
4. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
5. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
Romano M; Maddox JF; Serhan CN
J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
[TBL] [Abstract][Full Text] [Related]
6. The effects of vasoactive intestinal peptide on human natural killer cell function.
Rola-Pleszczynski M; Bolduc D; St-Pierre S
J Immunol; 1985 Oct; 135(4):2569-73. PubMed ID: 2993412
[TBL] [Abstract][Full Text] [Related]
7. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
8. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes.
Abrams SI; Brahmi Z
J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820
[TBL] [Abstract][Full Text] [Related]
9. Role of lipoxygenation in human natural killer cell activation.
Bray RA; Brahmi Z
J Immunol; 1986 Mar; 136(5):1783-90. PubMed ID: 3081633
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human natural killer cell activity by pharmacological mediators.
Hall TJ; Chen SH; Brostoff J; Lydyard PM
Clin Exp Immunol; 1983 Nov; 54(2):493-500. PubMed ID: 6317242
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.
Goto T; Herberman RB; Maluish A; Strong DM
J Immunol; 1983 Mar; 130(3):1350-5. PubMed ID: 6185577
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 depresses natural cytotoxicity by inhibiting interleukin-1 production by large granular lymphocytes.
Herman J; Rabson AR
Clin Exp Immunol; 1984 Aug; 57(2):380-4. PubMed ID: 6331926
[TBL] [Abstract][Full Text] [Related]
13. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
Luger TA; Uchida A; Köck A; Colot M; Micksche M
J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
[TBL] [Abstract][Full Text] [Related]
14. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
Brahmi Z; Bray RA; Abrams SI
J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
[TBL] [Abstract][Full Text] [Related]
16. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor.
Miller JS; Cervenka T; Lund J; Okazaki IJ; Moss J
J Immunol; 1999 Jun; 162(12):7376-82. PubMed ID: 10358189
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
18. Effect of local anaesthetics on human natural killer cell activity.
Takagi S; Kitagawa S; Oshimi K; Takaku F; Miura Y
Clin Exp Immunol; 1983 Aug; 53(2):477-81. PubMed ID: 6883810
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
Hiserodt JC; Britvan L; Targan SR
J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
[TBL] [Abstract][Full Text] [Related]
20. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]